comparemela.com
  1. Home
  2. Live Updates
  3. Ann Tivey - Breaking News

Latest Breaking News On - Ann tivey - Page 1 : comparemela.com

Observational Study Shows Frontline Ibrutinib With/Without Rituximab Is Safe and Effective in Low-Risk Mantle Cell Lymphoma

Ibrutinib with or without rituximab was effective and tolerable in patients with previously untreated, low-risk mantle cell lymphoma.

United kingdomIbrutinib imbruvicaAnn tiveyInternational prognostic score indexUniversity of manchesterPrognostic score indexMantle cell lymphoma

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.